The Latest Breaking News from Covid-19

Pfizer's COVID-19 pill will soon be available across the US

WASHINGTON — The U.S. government is finishing plans to make Pfizer Inc.’s COVID-19 pill available at any pharmacy across the country, with supply increasing as the BA.2 subvariant drives an uptick in cases and hospitalizations.

Tribune News Service · Apr 22, 2022

Canada draws 1 million travelers in one week for first time since pandemic

Canada attracted more than one million travelers in a week for the first time since the pandemic, government data showed on Friday, as easing of COVID-19 border restrictions encouraged visitors back into the country.

Reuters · Apr 22, 2022

COVID rules are winding back, but some Australians are still locking down

Cities around the country are again heaving with life, but many of the approximately 500,000 Australians who are severely immunocompromised are left fearing for their health.

ABC News · Apr 22, 2022

How do you detect drink spiking and what can be done about it?

With clubs and pubs reopening to capacity crowds once more, experts fear cases of drink spiking may be on the rise

The Guardian - AU · Apr 22, 2022

Covid funding to states should be extended, Daniel Andrews says

Victorian government wants extension of commonwealth funding arrangement to combat pandemic

The Guardian - AU · Apr 22, 2022

Police issue fines for bring your own booze Downing Street party, reports say

The police have reportedly started handing out fixed-penalty notices in relation to a staff drinks do during England’s first lockdown.

Evening Standard · Apr 22, 2022

COVID-19 third leading cause of death again in 2021- U.S. study

COVID-19 was the third leading cause of death in the United States for the second year in a row in 2021, with death rates rising for most age groups, a government study showed on Friday.

Reuters · Apr 22, 2022

IIT Madras designed study on COVID-19 drug published in Nature magazine

Researchers hope ICMR will include the drug in treatment protocol

The Hindu · Apr 22, 2022

Why This Analyst Thinks Tenet Healthcare's 'Q1 In Line On Solid Execution'

RBC Capital Markets views Tenet Healthcare Corp's (NYSE:THC) Q1 earnings in-line with expectations reflecting solid execution and labor cost management amid January omicron headwinds.  The analysts have raised the price target from $89 to $104 (41% upside) with an Outperform rating. Against an increasingly difficult labor backdrop characterized by high agency utilization, Tenet could hold…

Benzinga · Apr 22, 2022

‘Bring your own booze!’: what happened at No 10 on 20 May 2020?

Explainer: the British government reiterated Covid lockdown rules to the public – before staff headed to the garden

The Guardian - UK · Apr 22, 2022